Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Nobel Biocare clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany, Italy, Switzerland, USA, France, Spain, Netherlands, Sweden, Denmark, Austria, Norway, Portugal and Australia registers with Nobel Biocare as lead sponsor. Synced 17 Nov 2026
3Current trials
1Recruiting now
0Drugs in these trials
13Trial registers
At a glance

Nobel Biocare is the lead sponsor of 3 current clinical trials in our Germany, Italy, Switzerland, USA, France, Spain, Netherlands, Sweden, Denmark, Austria, Norway, Portugal and Australia registers. 1 is recruiting patients now. The most common phase is Observational. The most-studied condition is Marginal Bone Level Change.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open133%
  • Active, closed133%

Trials by phase

  • Observational267%
  • Not applicable133%
01

Clinical trials sponsored by Nobel Biocare

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Creos Xenoprotect PMCF
NCT07153185 · ClinicalTrials.gov ↗ · Bone Regeneration, Dental Implants, Bone Grafting
Observational Recruiting 2026-03 Germany
NobelZygoma TiUltra Implant System Study
NCT07258940 · ClinicalTrials.gov ↗ · Edentulous Maxilla, Maxillary Bone Loss, Atrophic Maxilla
Not applicable Not yet open 2026-06 Italy, Switzerland
A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components
NCT04737421 · Marginal Bone Level Change
Observational Active, closed 2021-05 USA, Germany, France, Spain, Italy, Netherlands, Sweden, Denmark, Switzerland, Austria, Norway, Portugal, Australia

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Nobel Biocare trials

7 conditions
Marginal Bone Level Change1Bone Regeneration1Dental Implants1Bone Grafting1Edentulous Maxilla1Maxillary Bone Loss1Atrophic Maxilla1
04

Questions about Nobel Biocare trials

How many clinical trials does Nobel Biocare sponsor?

Nobel Biocare is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Germany, Italy, Switzerland, USA, France, Spain, Netherlands, Sweden, Denmark, Austria, Norway, Portugal and Australia registers, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Nobel Biocare trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.